课题基金 / 基金详情

Neural probe for high spatial and temporal resolution detection of cocaine and GA

Neural probe for high spatial and temporal resolution detection of cocaine and GA
用于高空间和时间分辨率检测可卡因和 GA 的神经探针
批准号:
8650813
负责人:
Brian Glenn Jamieson
金额:
$39.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-01 至 2016-04-30

项目摘要

项目成果

Brian Glenn Jamieson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请的具体目的是测试开发用于快速测量大脑中多种神经化学物质的持久、可植入探针的可行性。目前,神经科学研究仅限于三种测量体内神经化学物质浓度的技术:微透析,以获得相对较长时间内的平均浓度(5-20分钟),酶基生物传感器在相对较大的空间区域内每秒检测一种神经化学物质(500 μ m长的电极)和碳纤维微电极以用快速扫描循环伏安法(FSCV)检测多巴胺。需要一种新的工具来快速检测细胞水平上具有空间分辨率的多种神经化学物质的浓度。这样的工具将允许神经科学研究人员提出有关大脑生理学,疾病状态和行为(如药物消耗)背后机制的新问题。所提出的神经探针通过以50 μ m的空间分辨率每4秒检测两种神经化学物质来满足这一需求。拟议中的探针将检测可卡因和GABA,这是一种暗示可卡因成瘾的神经递质,这是至少140万美国人基本上未经治疗的祸害。SB Microsystems已经开发出一种专有的MEMS工艺,用于制造可植入的多部位神经探针,用于研究啮齿动物的大脑。我们现有的探针的特征尺寸允许比现有的基于酶的电极提高10倍的空间分辨率。所提出的探针将建立在我们现有的平台上,通过用适体分子功能化探针位点表面来检测特定的神经化学物质。多种神经化学物质的检测将通过将不同的神经化学特异性检测分子图案化到相邻的探针位点上来实现。我们的I期申请将通过以下方式确定这些探针商业化的可行性:1)通过调整适体分子修饰、固定技术和电信号检测来改善功能化探针制造,以实现最佳可能的灵敏度和时间响应,2)开发用于检测的恒电位电路,3)开发用于特异性、灵敏性和持久检测的新型适体, GABA和可卡因接下来,我们将4)用新开发的适体使探针功能化以检测多种分析物,以及5)将探针植入大鼠体内以进行体内数据收集。该I期可行性研究的成功将通过使用在体内稳定2天的探针准确检测可卡因和GABA的生理相关浓度来确定。在第二阶段,我们计划开发更多的适体,可以应用到我们的探针检测超过2种神经递质。我们将使用稳健设计的原则,将我们的原型变成商业产品。所附的支持信表明,我们可能能够出售一个成功的原型,从第一阶段的神经科学研究人员。
英文摘要
DESCRIPTION (provided by applicant): The specific aim of this application is to test the feasibility of developing a long-lasting, implantable probe for rapid measurement of multiple neurochemicals in the brain. Currently, neuroscience research is limited to three techniques for measuring the concentrations of neurochemicals in vivo; microdialysis to obtain average concentrations over a relatively long time period (5-20 minutes), enzyme-based biosensors to detect a single neurochemical every second over a relatively large spatial area (500¿m length electrode), and carbon-fiber microelectrodes to detect dopamine with fast scan cyclic voltammetry (FSCV). A new tool is required for rapid detection of concentrations of multiple neurochemicals with spatial resolution on the cellular level. Such a tool would allow neuroscience researchers to ask new questions about the mechanisms behind brain physiology, disease states, and behaviors, such as drug consumption. The proposed neural probe fulfills this need by detecting two neurochemicals every 4 seconds with 50 ¿m spatial resolution. The proposed probe will detect cocaine and GABA, a neurotransmitter implied in cocaine addiction, which is an essentially untreated scourge of at least 1.4 million Americans. SB Microsystems has already developed a proprietary MEMS process for fabricating implantable, multi-site neural probes for studying the rodent brain. Our existing probes have the feature size that allows for a 10-fold spatial resolution improvement over the available enzyme-based electrodes. The proposed probe will build on our existing platform by functionalizing the probe site surfaces with aptamer molecules for the detection of specific neurochemicals. Detection of multiple neurochemicals will be achieved by patterning different neurochemical-specific detection molecules onto adjacent probe sites. Our Phase I application will determine feasibility for commercialization of these probes by; 1) improving functionalized probe fabrication by adjusting aptamer molecule modifications, immobilization technique, and electrical signal detection to achieve the best possible sensitivity and time response, 2) developing a potentiostat circuit for detection, 3) developing a novel aptamer for the specific, sensitive, and long-lasting detection of GABA and cocaine. Next, we will 4) functionalize the probe to detect multiple analytes with the newly developed aptamers and 5) implant probes into rats for in vivo data collection. Success in this Phase I feasibility study will be determined by the accurate detection of physiologically relevant concentrations of cocaine and GABA by probes that are stable in vivo for 2 days. In Phase II, we plan to develop more aptamers that can be applied to our probes for the detection of more than 2 neurotransmitters. We will use principles of robust design to turn our prototype into a commercial product. The attached letters of support indicate that we may be able to sell a successful prototype from Phase I to neuroscience researchers.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1039/c7tb00095b
发表时间: 2017-04-07
期刊: Journal of materials chemistry. B
影响因子: --
作者: [Taylor IM, Du Z, Bigelow ET, Eles JR, Horner AR, Catt KA, Weber SG, Jamieson BG, Cui XT]
通讯作者: Cui XT
Microfabricated tool for integrated PK/PD studies of CNS drugs
  • 批准号:
    9042433
  • 项目类别:
  • 资助金额:
    $38.45万
  • 财政年份:
    2015
  • 负责人:
    Brian Glenn Jamieson
  • 依托单位:
Indwelling Biosensor for real-time chemotherapeutic blood level monitoring
  • 批准号:
    9251900
  • 项目类别:
  • 资助金额:
    $66.41万
  • 财政年份:
    2014
  • 负责人:
    Brian Glenn Jamieson
  • 依托单位:
Indwelling Biosensor for real-time chemotherapeutic blood level monitoring
  • 批准号:
    9056221
  • 项目类别:
  • 资助金额:
    $66.41万
  • 财政年份:
    2014
  • 负责人:
    Brian Glenn Jamieson
  • 依托单位:
Indwelling biosensor for real-time chemotherapeutic blood level monitoring
  • 批准号:
    8839582
  • 项目类别:
  • 资助金额:
    $22.19万
  • 财政年份:
    2014
  • 负责人:
    Brian Glenn Jamieson
  • 依托单位:
海外基金